Correlation Between Nascent Biotech and Biotron
Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and Biotron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and Biotron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nascent Biotech and Biotron Limited, you can compare the effects of market volatilities on Nascent Biotech and Biotron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of Biotron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and Biotron.
Diversification Opportunities for Nascent Biotech and Biotron
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Nascent and Biotron is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and Biotron Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotron Limited and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with Biotron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotron Limited has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and Biotron go up and down completely randomly.
Pair Corralation between Nascent Biotech and Biotron
Given the investment horizon of 90 days Nascent Biotech is expected to generate 4.5 times more return on investment than Biotron. However, Nascent Biotech is 4.5 times more volatile than Biotron Limited. It trades about 0.09 of its potential returns per unit of risk. Biotron Limited is currently generating about -0.17 per unit of risk. If you would invest 5.50 in Nascent Biotech on August 28, 2024 and sell it today you would earn a total of 0.29 from holding Nascent Biotech or generate 5.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Nascent Biotech vs. Biotron Limited
Performance |
| Timeline |
| Nascent Biotech |
| Biotron Limited |
Nascent Biotech and Biotron Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nascent Biotech and Biotron
The main advantage of trading using opposite Nascent Biotech and Biotron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, Biotron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will offset losses from the drop in Biotron's long position.| Nascent Biotech vs. Protokinetix | Nascent Biotech vs. Silo Pharma | Nascent Biotech vs. Vg Life Sciences | Nascent Biotech vs. Mymetics Corp |
| Biotron vs. biOasis Technologies | Biotron vs. Covalon Technologies | Biotron vs. Mosaic Immunoengineering | Biotron vs. Cellectis SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |